GEN Exclusives

More »

GEN News Highlights

More »
May 22, 2007

TMO Licenses Integrated Genomics’ Software to Advance its Bioethanol Program

  • TMO Renewables gained access to Integrated Genomics’ ERGO™ bioinformatics software that will aid in itsbioethanol production research. 

    “We believe we have developed uniquely talented high-temperature process organisms capable of producing bioethanol quickly and efficiently from a wide diversity of sustainable cellulosic feedstocks,” says Steven Martin, Ph.D., associate R&D director at TMO. “The ERGO platform will enable us to further understand and exploit our thermophilic strains to their fullest potential to deliver the next generation of green biofuels.”

    TMO will utilize the ERGO genome analysis tools for gene annotation, metabolic reconstruction, enzyme data-mining, as well as comparative genomics. The tecnology integrates biological data from genomics, biochemistry, gene-expression studies, genetics, and literature. The platform combines pattern-based analyses with comparative genomics tools for gene visualization in the contexts of regulation, expression data, phylogeny, chromosomal neighborhoods, and gene fusions. ERGO contains more than 1,180 genomes at various stages of completion as well as the largest available collection of networked cellular pathways, according to the TMO.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »